Korean Drug Co Ltd
Company Profile
Business description
Korean Drug Co Ltd is engaged in the business of manufacture and sale of pharmaceuticals. Its products include comprehensive cold remedies, hematopoietic nutrients, central nervous system agents, digestive system agents, dermatological agents, vitamins/nutritional supplements, antibiotics, antibacterials, antipyretics, analgesics, and anti-inflammatory agents. The group manufacture and sell over-the-counter medications, including Haben, Korea's cold remedy, as well as prescription drugs for various conditions, including central nervous system (CNS) diseases such as dementia, epilepsy, stroke, and Parkinson's disease.
Contact
69-10 Wonjeok-ro
Sindun-myeon
Gyeonggi-do
Icheon-si
KORT: +82 316347100
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
240
Stocks News & Analysis
stocks
The best way to get rich and retire early
stocks
Investors overly negative on cheap ASX share
stocks
Overvalued US AI play reports earnings
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,096.20 | 77.60 | 0.86% |
| CAC 40 | 8,095.11 | 25.96 | -0.32% |
| DAX 40 | 24,282.74 | 1.23 | -0.01% |
| Dow JONES (US) | 48,362.68 | 227.79 | 0.47% |
| FTSE 100 | 9,854.26 | 11.71 | -0.12% |
| HKSE | 25,774.14 | 27.63 | -0.11% |
| NASDAQ | 23,428.83 | 121.21 | 0.52% |
| Nikkei 225 | 50,412.87 | 10.48 | 0.02% |
| NZX 50 Index | 13,517.73 | 9.43 | 0.07% |
| S&P 500 | 6,878.49 | 0.00 | 0.00% |
| S&P/ASX 200 | 8,795.70 | 78.80 | 0.90% |
| SSE Composite Index | 3,919.98 | 2.61 | 0.07% |